These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33302292)

  • 1. iDMer: an integrative and mechanism-driven response system for identifying compound interventions for sudden virus outbreak.
    Wei Z; Gao Y; Meng F; Chen X; Gong Y; Zhu C; Ju B; Zhang C; Liu Z; Liu Q
    Brief Bioinform; 2021 Mar; 22(2):976-987. PubMed ID: 33302292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA Viromics of Southern California Wastewater and Detection of SARS-CoV-2 Single-Nucleotide Variants.
    Rothman JA; Loveless TB; Kapcia J; Adams ED; Steele JA; Zimmer-Faust AG; Langlois K; Wanless D; Griffith M; Mao L; Chokry J; Griffith JF; Whiteson KL
    Appl Environ Microbiol; 2021 Nov; 87(23):e0144821. PubMed ID: 34550753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.
    Kim CH
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nosocomial Outbreak of SARS-CoV-2 in a "Non-COVID-19" Hospital Ward: Virus Genome Sequencing as a Key Tool to Understand Cryptic Transmission.
    Borges V; Isidro J; Macedo F; Neves J; Silva L; Paiva M; Barata J; Catarino J; Ciobanu L; Duarte S; Vieira L; Guiomar R; Gomes JP
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33916205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing the identification effectiveness of an unknown outbreak of the Infectious Diseases Seeker (IDS) using and comparing the novel coronavirus disease (COVID-19) outbreak with the past SARS and MERS epidemics.
    Baldassi F; Cenciarelli O; Malizia A; Gaudio P
    J Infect Public Health; 2021 Jan; 14(1):123-130. PubMed ID: 33412372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative host-pathogen protein-protein interaction analysis of recent coronavirus outbreaks and important host targets identification.
    Khan AA; Khan Z
    Brief Bioinform; 2021 Mar; 22(2):1206-1214. PubMed ID: 32914167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Structurally Conserved RNA Element within SARS-CoV-2 ORF1a RNA and S mRNA Regulates Translation in Response to Viral S Protein-Induced Signaling in Human Lung Cells.
    Basu A; Penumutchu S; Nguyen K; Mbonye U; Tolbert BS; Karn J; Komar AA; Mazumder B
    J Virol; 2022 Jan; 96(2):e0167821. PubMed ID: 34757848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients.
    Olbei M; Hautefort I; Modos D; Treveil A; Poletti M; Gul L; Shannon-Lowe CD; Korcsmaros T
    Front Immunol; 2021; 12():629193. PubMed ID: 33732251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system.
    Zhu Q; Zhang Y; Wang L; Yao X; Wu D; Cheng J; Pan X; Liu H; Yan Z; Gao L
    Antiviral Res; 2021 Mar; 187():105015. PubMed ID: 33444702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV.
    Milewska A; Chi Y; Szczepanski A; Barreto-Duran E; Dabrowska A; Botwina P; Obloza M; Liu K; Liu D; Guo X; Ge Y; Li J; Cui L; Ochman M; Urlik M; Rodziewicz-Motowidlo S; Zhu F; Szczubialka K; Nowakowska M; Pyrc K
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33219167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A delayed resurgence of respiratory syncytial virus (RSV) during the COVID-19 pandemic: An unpredictable outbreak in a small proportion of children in the Southwest of Iran, April 2022.
    Mohebi L; Karami H; Mirsalehi N; Ardestani NH; Yavarian J; Mard-Soltani M; Mokhatri-Azad T; Salimi V
    J Med Virol; 2022 Dec; 94(12):5802-5807. PubMed ID: 35961780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy, Unfolded Protein Response, and Neuropilin-1 Cross-Talk in SARS-CoV-2 Infection: What Can Be Learned from Other Coronaviruses.
    Siri M; Dastghaib S; Zamani M; Rahmani-Kukia N; Geraylow KR; Fakher S; Keshvarzi F; Mehrbod P; Ahmadi M; Mokarram P; Coombs KM; Ghavami S
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34206057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
    Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triazavirin might be the new hope to fight Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Hudecová IMJČGKMPL
    Ceska Slov Farm; 2021; 70(1):18-25. PubMed ID: 34237949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance.
    Anisul M; Shilts J; Schwartzentruber J; Hayhurst J; Buniello A; Shaikho Elhaj Mohammed E; Zheng J; Holmes M; Ochoa D; Carmona M; Maranville J; Gaunt TR; Emilsson V; Gudnason V; McDonagh EM; Wright GJ; Ghoussaini M; Dunham I
    Elife; 2021 Aug; 10():. PubMed ID: 34402426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in membrane-fusion subunit of spike glycoprotein play crucial role in the recent outbreak of COVID-19.
    Podder S; Ghosh A; Ghosh T
    J Med Virol; 2021 May; 93(5):2790-2798. PubMed ID: 33090493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.